mechanism two classes cancer mutations phosphoinositide kinase catalytic subunit 
many human cancers involve up-regulation phosphoinositide kinase pi3k alpha oncogenic mutations identified p110 alpha catalytic p85 alpha regulatory subunits used crystallographic biochemical approaches gain insight activating mutations two noncatalytic p110 alpha domains-the adaptor-binding helical domains structure adaptor-binding domain p110 alpha complex p85 alpha inter-src homology inter-sh2 domain shows oncogenic mutations adaptor-binding domain inter-sh2 interface polar surface patch plausible docking site domains holo p110/p85 complex also examined helical domain mutations found glu lys e545k oncogenic mutant disrupts inhibitory charge-charge interaction p85 n-terminal sh2 domain studies extend understanding architecture pi3ks provide insight two classes mutations cause gain function can lead cancer 
